Biotech Values

[rkrw]

<<Eventually, there will not be any gain -- no gain whatsoever -- and we will be left with no patent challenges," Rakoczy said. "You're talking about an industrywide change.">>

Quite an exaggeration. Maybe a minimum sales threshold to make the challenge worth it.

Per a recent PR, Teva has 50+ current patent challenges. I found this to be an astounding figure. Whole generic industry has become challenge first, understand the patent later. Big Rx is under enormous pressure, should only help innovative bio's....

Incidentally, authorized generics have been around for at least 10 years.